Pancreatic Beta-Cell Protection Market
1 Introduction to Research & Analysis Reports
1.1 Pancreatic Beta-Cell Protection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pancreatic Beta-Cell Protection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pancreatic Beta-Cell Protection Overall Market Size
2.1 Global Pancreatic Beta-Cell Protection Market Size: 2021 VS 2028
2.2 Global Pancreatic Beta-Cell Protection Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pancreatic Beta-Cell Protection Players in Global Market
3.2 Top Global Pancreatic Beta-Cell Protection Companies Ranked by Revenue
3.3 Global Pancreatic Beta-Cell Protection Revenue by Companies
3.4 Top 3 and Top 5 Pancreatic Beta-Cell Protection Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pancreatic Beta-Cell Protection Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pancreatic Beta-Cell Protection Players in Global Market
3.6.1 List of Global Tier 1 Pancreatic Beta-Cell Protection Companies
3.6.2 List of Global Tier 2 and Tier 3 Pancreatic Beta-Cell Protection Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Pancreatic Beta-Cell Protection Market Size Markets, 2021 & 2028
4.1.2 Stem Cell Based
4.1.3 Gene Therapies
4.1.4 RNA Based Therapies
4.1.5 Monoclonal Antibodies (MAbs)
4.1.6 Phytotherapy
4.2 By Type - Global Pancreatic Beta-Cell Protection Revenue & Forecasts
4.2.1 By Type - Global Pancreatic Beta-Cell Protection Revenue, 2017-2022
4.2.2 By Type - Global Pancreatic Beta-Cell Protection Revenue, 2023-2028
4.2.3 By Type - Global Pancreatic Beta-Cell Protection Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pancreatic Beta-Cell Protection Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Medical Research Laboratory
5.1.4 Others
5.2 By Application - Global Pancreatic Beta-Cell Protection Revenue & Forecasts
5.2.1 By Application - Global Pancreatic Beta-Cell Protection Revenue, 2017-2022
5.2.2 By Application - Global Pancreatic Beta-Cell Protection Revenue, 2023-2028
5.2.3 By Application - Global Pancreatic Beta-Cell Protection Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Pancreatic Beta-Cell Protection Market Size, 2021 & 2028
6.2 By Region - Global Pancreatic Beta-Cell Protection Revenue & Forecasts
6.2.1 By Region - Global Pancreatic Beta-Cell Protection Revenue, 2017-2022
6.2.2 By Region - Global Pancreatic Beta-Cell Protection Revenue, 2023-2028
6.2.3 By Region - Global Pancreatic Beta-Cell Protection Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Pancreatic Beta-Cell Protection Revenue, 2017-2028
6.3.2 US Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.3.3 Canada Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.3.4 Mexico Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Pancreatic Beta-Cell Protection Revenue, 2017-2028
6.4.2 Germany Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.4.3 France Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.4.4 U.K. Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.4.5 Italy Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.4.6 Russia Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.4.7 Nordic Countries Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.4.8 Benelux Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Pancreatic Beta-Cell Protection Revenue, 2017-2028
6.5.2 China Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.5.3 Japan Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.5.4 South Korea Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.5.5 Southeast Asia Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.5.6 India Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Pancreatic Beta-Cell Protection Revenue, 2017-2028
6.6.2 Brazil Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.6.3 Argentina Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pancreatic Beta-Cell Protection Revenue, 2017-2028
6.7.2 Turkey Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.7.3 Israel Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.7.4 Saudi Arabia Pancreatic Beta-Cell Protection Market Size, 2017-2028
6.7.5 UAE Pancreatic Beta-Cell Protection Market Size, 2017-2028
7 Players Profiles
7.1 ViaCyte
7.1.1 ViaCyte Corporate Summary
7.1.2 ViaCyte Business Overview
7.1.3 ViaCyte Pancreatic Beta-Cell Protection Major Product Offerings
7.1.4 ViaCyte Pancreatic Beta-Cell Protection Revenue in Global Market (2017-2022)
7.1.5 ViaCyte Key News
7.2 PharmaCyte Biotech
7.2.1 PharmaCyte Biotech Corporate Summary
7.2.2 PharmaCyte Biotech Business Overview
7.2.3 PharmaCyte Biotech Pancreatic Beta-Cell Protection Major Product Offerings
7.2.4 PharmaCyte Biotech Pancreatic Beta-Cell Protection Revenue in Global Market (2017-2022)
7.2.5 PharmaCyte Biotech Key News
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporate Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Pancreatic Beta-Cell Protection Major Product Offerings
7.3.4 Boehringer Ingelheim Pancreatic Beta-Cell Protection Revenue in Global Market (2017-2022)
7.3.5 Boehringer Ingelheim Key News
7.4 GalaxoSmithKline
7.4.1 GalaxoSmithKline Corporate Summary
7.4.2 GalaxoSmithKline Business Overview
7.4.3 GalaxoSmithKline Pancreatic Beta-Cell Protection Major Product Offerings
7.4.4 GalaxoSmithKline Pancreatic Beta-Cell Protection Revenue in Global Market (2017-2022)
7.4.5 GalaxoSmithKline Key News
7.5 Beta-Cell NV
7.5.1 Beta-Cell NV Corporate Summary
7.5.2 Beta-Cell NV Business Overview
7.5.3 Beta-Cell NV Pancreatic Beta-Cell Protection Major Product Offerings
7.5.4 Beta-Cell NV Pancreatic Beta-Cell Protection Revenue in Global Market (2017-2022)
7.5.5 Beta-Cell NV Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Pancreatic Beta-Cell Protection Major Product Offerings
7.6.4 Novartis Pancreatic Beta-Cell Protection Revenue in Global Market (2017-2022)
7.6.5 Novartis Key News
7.7 Janssen Research & Development
7.7.1 Janssen Research & Development Corporate Summary
7.7.2 Janssen Research & Development Business Overview
7.7.3 Janssen Research & Development Pancreatic Beta-Cell Protection Major Product Offerings
7.7.4 Janssen Research & Development Pancreatic Beta-Cell Protection Revenue in Global Market (2017-2022)
7.7.5 Janssen Research & Development Key News
7.8 Pfizer Inc
7.8.1 Pfizer Inc Corporate Summary
7.8.2 Pfizer Inc Business Overview
7.8.3 Pfizer Inc Pancreatic Beta-Cell Protection Major Product Offerings
7.8.4 Pfizer Inc Pancreatic Beta-Cell Protection Revenue in Global Market (2017-2022)
7.8.5 Pfizer Inc Key News
7.9 BioLineRx
7.9.1 BioLineRx Corporate Summary
7.9.2 BioLineRx Business Overview
7.9.3 BioLineRx Pancreatic Beta-Cell Protection Major Product Offerings
7.9.4 BioLineRx Pancreatic Beta-Cell Protection Revenue in Global Market (2017-2022)
7.9.5 BioLineRx Key News
7.10 Genentech
7.10.1 Genentech Corporate Summary
7.10.2 Genentech Business Overview
7.10.3 Genentech Pancreatic Beta-Cell Protection Major Product Offerings
7.10.4 Genentech Pancreatic Beta-Cell Protection Revenue in Global Market (2017-2022)
7.10.5 Genentech Key News
7.11 Novo Nordisk
7.11.1 Novo Nordisk Corporate Summary
7.11.2 Novo Nordisk Business Overview
7.11.3 Novo Nordisk Pancreatic Beta-Cell Protection Major Product Offerings
7.11.4 Novo Nordisk Pancreatic Beta-Cell Protection Revenue in Global Market (2017-2022)
7.11.5 Novo Nordisk Key News
7.12 Sanofi
7.12.1 Sanofi Corporate Summary
7.12.2 Sanofi Business Overview
7.12.3 Sanofi Pancreatic Beta-Cell Protection Major Product Offerings
7.12.4 Sanofi Pancreatic Beta-Cell Protection Revenue in Global Market (2017-2022)
7.12.5 Sanofi Key News
7.13 Osiris Therapeutics
7.13.1 Osiris Therapeutics Corporate Summary
7.13.2 Osiris Therapeutics Business Overview
7.13.3 Osiris Therapeutics Pancreatic Beta-Cell Protection Major Product Offerings
7.13.4 Osiris Therapeutics Pancreatic Beta-Cell Protection Revenue in Global Market (2017-2022)
7.13.5 Osiris Therapeutics Key News
7.14 Beta-O2 Technologies Ltd
7.14.1 Beta-O2 Technologies Ltd Corporate Summary
7.14.2 Beta-O2 Technologies Ltd Business Overview
7.14.3 Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Major Product Offerings
7.14.4 Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Revenue in Global Market (2017-2022)
7.14.5 Beta-O2 Technologies Ltd Key News
7.15 Transition Therapeutics
7.15.1 Transition Therapeutics Corporate Summary
7.15.2 Transition Therapeutics Business Overview
7.15.3 Transition Therapeutics Pancreatic Beta-Cell Protection Major Product Offerings
7.15.4 Transition Therapeutics Pancreatic Beta-Cell Protection Revenue in Global Market (2017-2022)
7.15.5 Transition Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Pancreatic Beta-Cell Protection Market Opportunities & Trends in Global Market
Table 2. Pancreatic Beta-Cell Protection Market Drivers in Global Market
Table 3. Pancreatic Beta-Cell Protection Market Restraints in Global Market
Table 4. Key Players of Pancreatic Beta-Cell Protection in Global Market
Table 5. Top Pancreatic Beta-Cell Protection Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pancreatic Beta-Cell Protection Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pancreatic Beta-Cell Protection Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pancreatic Beta-Cell Protection Product Type
Table 9. List of Global Tier 1 Pancreatic Beta-Cell Protection Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pancreatic Beta-Cell Protection Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pancreatic Beta-Cell Protection Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pancreatic Beta-Cell Protection Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pancreatic Beta-Cell Protection Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pancreatic Beta-Cell Protection Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pancreatic Beta-Cell Protection Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pancreatic Beta-Cell Protection Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2023-2028
Table 30. ViaCyte Corporate Summary
Table 31. ViaCyte Pancreatic Beta-Cell Protection Product Offerings
Table 32. ViaCyte Pancreatic Beta-Cell Protection Revenue (US$, Mn), (2017-2022)
Table 33. PharmaCyte Biotech Corporate Summary
Table 34. PharmaCyte Biotech Pancreatic Beta-Cell Protection Product Offerings
Table 35. PharmaCyte Biotech Pancreatic Beta-Cell Protection Revenue (US$, Mn), (2017-2022)
Table 36. Boehringer Ingelheim Corporate Summary
Table 37. Boehringer Ingelheim Pancreatic Beta-Cell Protection Product Offerings
Table 38. Boehringer Ingelheim Pancreatic Beta-Cell Protection Revenue (US$, Mn), (2017-2022)
Table 39. GalaxoSmithKline Corporate Summary
Table 40. GalaxoSmithKline Pancreatic Beta-Cell Protection Product Offerings
Table 41. GalaxoSmithKline Pancreatic Beta-Cell Protection Revenue (US$, Mn), (2017-2022)
Table 42. Beta-Cell NV Corporate Summary
Table 43. Beta-Cell NV Pancreatic Beta-Cell Protection Product Offerings
Table 44. Beta-Cell NV Pancreatic Beta-Cell Protection Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Pancreatic Beta-Cell Protection Product Offerings
Table 47. Novartis Pancreatic Beta-Cell Protection Revenue (US$, Mn), (2017-2022)
Table 48. Janssen Research & Development Corporate Summary
Table 49. Janssen Research & Development Pancreatic Beta-Cell Protection Product Offerings
Table 50. Janssen Research & Development Pancreatic Beta-Cell Protection Revenue (US$, Mn), (2017-2022)
Table 51. Pfizer Inc Corporate Summary
Table 52. Pfizer Inc Pancreatic Beta-Cell Protection Product Offerings
Table 53. Pfizer Inc Pancreatic Beta-Cell Protection Revenue (US$, Mn), (2017-2022)
Table 54. BioLineRx Corporate Summary
Table 55. BioLineRx Pancreatic Beta-Cell Protection Product Offerings
Table 56. BioLineRx Pancreatic Beta-Cell Protection Revenue (US$, Mn), (2017-2022)
Table 57. Genentech Corporate Summary
Table 58. Genentech Pancreatic Beta-Cell Protection Product Offerings
Table 59. Genentech Pancreatic Beta-Cell Protection Revenue (US$, Mn), (2017-2022)
Table 60. Novo Nordisk Corporate Summary
Table 61. Novo Nordisk Pancreatic Beta-Cell Protection Product Offerings
Table 62. Novo Nordisk Pancreatic Beta-Cell Protection Revenue (US$, Mn), (2017-2022)
Table 63. Sanofi Corporate Summary
Table 64. Sanofi Pancreatic Beta-Cell Protection Product Offerings
Table 65. Sanofi Pancreatic Beta-Cell Protection Revenue (US$, Mn), (2017-2022)
Table 66. Osiris Therapeutics Corporate Summary
Table 67. Osiris Therapeutics Pancreatic Beta-Cell Protection Product Offerings
Table 68. Osiris Therapeutics Pancreatic Beta-Cell Protection Revenue (US$, Mn), (2017-2022)
Table 69. Beta-O2 Technologies Ltd Corporate Summary
Table 70. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Product Offerings
Table 71. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Revenue (US$, Mn), (2017-2022)
Table 72. Transition Therapeutics Corporate Summary
Table 73. Transition Therapeutics Pancreatic Beta-Cell Protection Product Offerings
Table 74. Transition Therapeutics Pancreatic Beta-Cell Protection Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Pancreatic Beta-Cell Protection Segment by Type in 2021
Figure 2. Pancreatic Beta-Cell Protection Segment by Application in 2021
Figure 3. Global Pancreatic Beta-Cell Protection Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pancreatic Beta-Cell Protection Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pancreatic Beta-Cell Protection Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pancreatic Beta-Cell Protection Revenue in 2021
Figure 8. By Type - Global Pancreatic Beta-Cell Protection Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pancreatic Beta-Cell Protection Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pancreatic Beta-Cell Protection Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pancreatic Beta-Cell Protection Revenue Market Share, 2017-2028
Figure 12. US Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pancreatic Beta-Cell Protection Revenue Market Share, 2017-2028
Figure 16. Germany Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 17. France Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pancreatic Beta-Cell Protection Revenue Market Share, 2017-2028
Figure 24. China Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 28. India Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pancreatic Beta-Cell Protection Revenue Market Share, 2017-2028
Figure 30. Brazil Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pancreatic Beta-Cell Protection Revenue Market Share, 2017-2028
Figure 33. Turkey Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pancreatic Beta-Cell Protection Revenue, (US$, Mn), 2017-2028
Figure 37. ViaCyte Pancreatic Beta-Cell Protection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. PharmaCyte Biotech Pancreatic Beta-Cell Protection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Boehringer Ingelheim Pancreatic Beta-Cell Protection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GalaxoSmithKline Pancreatic Beta-Cell Protection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Beta-Cell NV Pancreatic Beta-Cell Protection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Pancreatic Beta-Cell Protection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Janssen Research & Development Pancreatic Beta-Cell Protection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pfizer Inc Pancreatic Beta-Cell Protection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. BioLineRx Pancreatic Beta-Cell Protection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Genentech Pancreatic Beta-Cell Protection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Novo Nordisk Pancreatic Beta-Cell Protection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Sanofi Pancreatic Beta-Cell Protection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Osiris Therapeutics Pancreatic Beta-Cell Protection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Transition Therapeutics Pancreatic Beta-Cell Protection Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
